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ScienceDirectThe serous cavities contain specialised adipose tissues which
house small clusters of immune cells known as fat-associated
lymphoid clusters (FALCs). The continuous flow of fluid from
the serous cavities through FALCs makes them unique niches
for the clearance of fluid phase contaminants and initiation of
locally protective immune responses during infection and
inflammation. Development, and activation of FALCs both at
homeostasis and following inflammation are co-ordinated by
the close interaction of mesothelial and fibroblastic stromal cell
populations with immune cells. In this review we discuss recent
developments in FALC stromal cell biology and highlight key
interactions that occur between FALC stroma and immune
cells.
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Introduction
Internal organs are contained in three fluid-filled serous
cavities: the peritoneum which envelops the abdominal
viscera [1] the pleural cavity enclosing the lungs [2] and
the pericardium which protects and anchors the heart [3].
These cavities are delimited by two membranes, the
parietal serosa covering the wall of the cavity and the
visceral serosa covering the organs. Fluid is secreted by
the mesothelium lining these membranes ensuring
lubrication of the serous cavities, free movement of
organs and continuous flow of fluid [4]. Fluid is drained
out of the cavities through stomata [4] found in the
mesothelium of certain visceral adipose tissues, such as
the membranous folds formed by the omentum and
mesenteries in the peritoneal cavity, the adipose tissue
of the mediastinum in the pleural cavity and the adiposeCurrent Opinion in Immunology 2020, 64:42–49 tissue of the pericardium. Dedicated immunological
niches called fat-associated lymphoid clusters (FALCs)
develop under the intercellular pores formed by stomata
[5,6] in the mesothelium of these visceral adipose tissues
and contribute to the barrier function of the mesothelium
and immune surveillance of serous cavities. FALCs were
first identified in the omentum where, historically, they
were called milky spots [7], knowledge of their existence
was later expanded to include other visceral adipose
tissues [8–10,11]. FALCs are important immune
activation and co-ordination hubs; possessing some
functions akin to lymph nodes but distinct in that they
are not encapsulated organs, enabling direct and more
immediate contact with contaminants (pathogens,
particulate material, PAMPs, DAMPs) within the cavities
in which they reside. Recent studies are beginning to
unpick the complex interactions between immune
and stromal cells within adipose organs. The FALCs,
as co-ordination hubs for body cavity immune responses
represent an important site for the analysis of adipose
stromal-immune interactions that take place just beyond
the mucosal frontline.
Structure of FALCs and function of FALC
stromal cells at homeostasis
Structure of FALCs
FALCs are a critical component of serous innate-B cell
function [12]. The recruitment of B cells to FALCs is
dependent on the homeostatic chemokine CXCL13 [13],
which is expressed by macrophages and radio-resistant
stromal cells [13] that form a 3-dimensional basket that
envelopes FALC B cells [14]. Recent work from our lab
confirmed that the expression of CXCL13 was limited to
the loose lining of mesothelial cells covering the serous
facing side of FALCs [15]. We called these cells
CXCL13+ FALC cover cells. In addition to CXCL13,
FALC cover cells express Podoplanin (also known as
gp38, Aggrus or T1alpha) and a number of factors
involved in the recruitment, adhesion or activation of
immune cells [15] suggesting that FALC cover cells
facilitate the extravasation of immune cells between
the serous cavities and FALCs (Table 1).
A distinct subset of stromal cells expressing the
homeostatic chemokine CCL19 is found at the heart of
the clusters [16]. These stromal cells form a reticular
network, expressing GP38 and the fibroblastic marker
PDGFRa, resembling fibroblastic reticular cells (FRCs)
and referred to as FALC FRCs. Lymph nodes contain
different subsets of FRCs contributing to variouswww.sciencedirect.com
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Table 1
Markers expressed by adipose and FALC stromal cells
FALC FRC FALC cover cells Adipose stromal cells Mesothelial cells References
CD31 – – – –
GP38 + + + +
PDGFRa + – + – [15,23]
CCL19 + – – – [15,16]
CXCL13 – + + + [14,15]
IL-33 + + + + [11,15, 24,25,26]
CCL2 + + – – [15,16]
WT1 + + + + [15,31]
RA – + + + [31]
CCL11 – – + – [15,24]structural and functional niches [17,18] including CCL19
expressing reticular cells found in the T-cell zone of
lymph nodes and called T-reticular cells. While T cells
are present in FALCs, there is no clear T-cell zone,
indicating that FALC FRCs constitute a unique subset
of lymphoid stromal cells with differing functional
capacity to FRCs found within lymph nodes.
FALCs are highly vascularised[19–21] with theendothelial
blood vasculature forming distinctive convolutions
resembling the renal glomeruli. FALCs can support the
differentiation of high endothelial venules (HEV). HEVs
are essential for lymphocyte trafficking in secondary organs
and in FALCs support the entrance of lymphocytes to the
serous cavities from the circulation. In addition, HEVs are
used by neutrophils to swiftly transit into the peritoneal
cavity during peritonitis [22]. In contrast to lymph nodes
which directly receive lymph through afferent collecting
lymphatics, FALCs are not exposed to lymph but to the
serous fluid entering through the mesothelial stomata.
Collecting lymphatic vessels are found in the vicinity of
FALCs to drain this fluid toward downstream lymph nodes
[19]. See composition of FALCs in Figure 1a.
The expression of IL-33 by FALC stromal cells supports
ILC2 function in FALCs
Group 2 innate lymphoid cells (ILC2) were first identified
in FALCs of the mesenteric adipose tissue [8], where in
response to IL-33, they secrete IL-5 which in turns
enables innate-B cell proliferation and IgM secretion
[8,11]. We found that GP38+CD31 FALC stromal
cells produce IL-33, which is sequestrated in their
nucleus [11]. Recent reports have now shown that IL-
33 is also present within mesenchymal cells interspersed
within, and mesothelial cells covering, adipose tissues.
IL-33 is emerging as a key regulator of adipose tissue
homeostasis by controlling type 2 immune cell recruit-
ment to adipose tissue [23,24,25,26,27]. In particular,
stromal adipose IL-33 promotes ILC2 secretion of IL-4
and IL-13 [23,26,27] triggering the expression of Ccl11
by mesenchymal adipose stromal cells which in turn
increases recruitment of eosinophils to adipose tissuewww.sciencedirect.com [24]. While PDGFRa+GP38+CD31 adipose stromal
cells have been shown to support the differentiation of
ILC2 progenitors [23], it is still not clear what promotes
the recruitment/survival of ILC2 in FALCs and the
adipose tissue stromal cell niche nor what proportion of
ILC2 are found in FALCs compared to the rest of the
adipose tissue. Interestingly, adipose tissues rich in
FALCs, such as the omentum, secrete high amounts of
IL-33 compared to adipose depots poor in FALCs [11],
suggesting that FALCs may concentrate IL-33 produc-
tion and ILC2 action in adipose tissue. We recently
confirmed by single-cell RNA sequencing the expression
of IL-33 by mesothelial cells and mesenchymal cells [15],
The role of stromal cell derived retinoids at homeostasis
All serous cavities are home to a population of self-
renewing cavity-resident macrophages [28–30,31],
important for clearance of pathogens in serous cavities
[28,32–34], tissue repair [35,36] and Ig production by
innate-B cells [37,38]. The maintenance and functional
identity of these cavity-resident macrophages rely on the
transcription factor GATA6 [37,39,40]. Gata6 expression
is induced by retinoic acid (RA), a derivative of retinol
(vitamin A) [31,37]. Mesothelial cells and fibroblastic
cells of the omentum and mesenteries express high levels
of two rate limiting enzymes required for the conversion
of retinol into RA, the retinaldehyde dehydrogenase
1 and 2 (Raldh1 and Raldh2) [32,37]. The transcription
factor Wilms tumour 1 (Wt1), which is required for the
development of all visceral adipose tissues including the
omental, pericardial and mesenteric depots [41] and is
expressed by both PDGFRa mesothelial cells and
PDGFRa+ fibroblasts in the omentum and mesenteries,
drives the expression of Raldh1 and Raldh2 [31].
Diphtheria-toxin mediated depletion of Wt1+ cells
diminishes the frequency of serous-resident macrophages
in the pericardial, pleural and peritoneal cavities confirm-
ing that Wt1 expressing cells are critical for the mainte-
nance of cavity-resident macrophages [31]. Single-cell
RNA sequencing analysis of omentum stroma confirmed
that mesothelial cells, FALC cover cells and adipose
stromal cells are competent to secrete RA while FALCCurrent Opinion in Immunology 2020, 64:42–49
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Structure of FALCs.
(a) FALC stroma is made of two main stromal cell populations: FALC FRCs expressing CCL19 and FALC cover cells expressing CXCL13. Serous
fluid enters FALCs through stomata made by the loose lining of FALC cover cells and drain through collective lymphatic vessels in the vicinity of
FALCs. Immune cells enter FALC from the circulation via HEVs and transit in and out of the serous cavity via stomata. (b) Mesothelial cells,
adipose stromal cells and FALC cover cells are competent to produce RA (1). RA induces the expression of GATA6 which is required to retain
cavity-resident macrophages (2) and the secretion of TGF-b (3) which induces IgA class-switching (4). RA also acts directly on innate-B cells,
inducing the expression of gut homing molecules (5) and is required for the expression of the transcription factor NFATc1 needed for the
development and function of innate-B cells (6).
Current Opinion in Immunology 2020, 64:42–49 www.sciencedirect.com
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may establish an RA rich environment important for
FALC B cell function. RA directly induces the expression
of the gut homing molecules integrin a4b7 and CCR9 by
innate-B cells [42] while GATA6-dependent secretion of
TGF-b2 by peritoneal macrophages promotes IgA class
switching in innate-B cells [37,43]. RA is also important
for the maintenance and function of innate-B cells via
control of NFATc1 expression [44,45]. See Figure 1b for
RA production by FALC and adipose stromal cells.
Signals controlling the formation of FALCs
and their maturation
During development and under homeostatic conditions
FALCs are first found in human omentum during foetal
development [46] and appear in the mouse mesenteries
during the first week after birth [10]. Recruitment of a
subset of RORgt-dependent innate lymphoid cells (ILC)
called lymphoid tissue inducer (LTi) cells expressing
Lymphotoxin a (LTa) that engage the Lymphotoxin b
receptor (LTbR) on mesenchymal cells is a critical step in
the development of secondary lymphoid organs. In par-
ticular LTbR signalling induces CXCL13 expression by
stromal cells of the lymph node anlagen, precipitating the
recruitment of CXCR5+ LTi cells [47–51]. In contrast,
the initiation of FALC formation is independent of
RORgt and LTbR signalling [10,14]. While the formation
of FALCs can be initiated in B and T cell deficient
Rag2/mice, FALCs are absent in Rag2/Il2rg/mice
suggesting that a subset of ILCs different from LTi is
required to trigger the initial formation of FALCs during
normal development. FALCs do form in Cxcl13/ mice
[14], but fail to recruit B cells. The expression of Cxcl13 is
not affected in LTa/ mice [14], indicating that Cxcl13
expression by FALC cover cells is not dependent on
LTa/LTbR signalling. Recent work showed that
TLR9 signalling in adipose stromal cells suppress
CXCL13 secretion and the recruitment of B cells in
the peritoneal cavity at homeostasis and during peritonitis
[52]. Additional work is required to determine what
controls the expression of CXCL13 and the differentia-
tion of FALC cover cells. Interestingly, both RA [53] and
interstitial fluid flow [54] have been shown to induce/
reinforce CXCL13 expression during lymph node forma-
tion, two pathways which could be acting during FALC
formation and which may have implications in disease
states where there is increased serous fluid for example
during peritoneal dialysis or malignant effusion [21].
FALCs are notably smaller and their number is reduced
in Tnfr1/Tnfr2/ mice [10] and in mice with a
conditional deletion of Myeloid differentiation primary
response 88 (MyD88) in Ccl19+ FRCs [16] indicating an
important role for TNF signalling and innate-immune
sensing for the development of FALCs. MyD88 signal-
ling controls transcriptional reprogramming of FALC
FRCs leading to increased expression of homeostaticwww.sciencedirect.com and inflammatory chemokines and extra-cellular matrix
proteins [16]. Germ free mice also show reduced
numbers of FALCs [10], indicating that the presence
of commensal microbes or their by-products sets an innate
inflammatory tone sensed by FALC FRCs to form and
mature a full complement of FALCs in the serous
cavities. Sensing of the environment by FALC FRCs is
likely to be facilitated by the constant flow of serous fluid
through FALCs bringing in pathogens and antigens.
Under acute inflammatory conditions
During peritonitis, neutrophils and inflammatory mono-
cytes rapidly enter FALCs to access the peritoneal cavity,
while peritoneal contaminants are captured by FALCs
[7,15,20,21]. In addition to the activation of existing
FALCs, peritonitis leads to swift de novo FALC forma-
tion. This is dependent on the production of TNF by
inflammatory monocyte/macrophages and TNFR-signal-
ling in stromal cells [10]. The initial recruitment of
inflammatory monocytes into FALCs requires MyD88-
dependent signalling within Ccl19 expressing FALC FRC
and the release of the monocyte chemoattractant CCL2
[16]. The cross-talk between monocyte/macrophage
and FALC FRCs thus plays a critical role in de novo
FALC formation. Natural Killer T cells (iNKT), a subset
of T cells-enriched in visceral adipose tissue [55], are
required to induce neo-formation of FALCs during acute
inflammation, an effect mediated through IL-4 and IL-13
[10]. This suggests that a cross-talk between iNKT cells
secreting IL-4/13 and FALC stromal cells expressing IL-
4R is required to induce FALC formation.
FALC stromal cells support B cell immune
responses
Innate-B cells
Upon sensing of inflammatory or infectious signals, serous
B cells migrate into FALCs where they undergo rapid
proliferation and start to release large amounts of poly-
reactive IgM to protect the serous space [11,12,56]. The
absence of IL-33 signalling via genetic deletion of Il1rl1
(IL-33R) results in a failure to activate pericardial &
mediastinal FALCs and a decrease in the levels of IgM
locally within the pleural cavity in response to infection or
allergic airway inflammation [11]. IL-33 does not act
directly on FALC B cells but most likely on ILC2 [8],
which respond by increased secretion of IL-5 enabling
rapid B cell proliferation and IgM secretion (Figure 2a)
[11]. Thus stromal-derived IL-33 is important not only
during homeostasis but early in response to infection or
inflammation within the serous cavities, the mechanisms
leading to release of IL-33 by FALC stromal cells are still
to be elucidated.
FALC FRC support T cell-dependent B cell immune
responses
FALCs support T cell-dependent immune responses,
including Ig isotype switching [10,14,18], somaticCurrent Opinion in Immunology 2020, 64:42–49
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Figure 2
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FALC stromal cells support B cell immune responses.
(a) FALC stromal cells support innate-B cell immune responses. CXCL13+ cover cells and CCL19+ FRCs express IL-33. Upon sensing of
infectious/inflammatory signals (1), release of IL-33 (2) induces increased secretion of IL-5 by ILC2 (3) leading to innate-B cell activation and IgM
secretion (4). (b) FALC FRCs support T cell-dependent B cell immune response to peritoneal antigens. During serous infections, pathogens and
antigens are filtered into FALCs (1) where MyD88 mediated-innate sensing of pathogens by CCL19+ FRCs (2) trigger CCL2 secretion (3) and
inflammatory monocyte recruitment (4). FALC FRC-monocyte cross-talk through TNF-TNFR signaling (5) is required for T-B cell interactions (6),
germinal center formation, class-switching, somatic hyper-mutation and affinity maturation (7).hypermutation, and limited affinity maturation [14],
despite the lack of identifiable follicular dendritic cells.
Although FALCs do not develop proper germinal centres
[14], B cells rapidly acquire a germinal centre–like
phenotype that can be assessed by the expression of first
apoptosis signal (FAS) and the T and B cell activation
marker GL7. Recent work by Perez-Shibayama usingCurrent Opinion in Immunology 2020, 64:42–49 FRC-restricted MyD88 ablation demonstrates that
FRC play a key role in CD4+ T cell-dependent B-cell
activation, the initiation of a germinal centre reaction
and IgG class switching during Salmonella infection.
Recruitment of inflammatory monocytes into FALCs
and bidirectional TNFR1/2 signalling between inflam-
matory monocytes and FRC mediates FRC activation andwww.sciencedirect.com
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ingly, the secretion of IgM by FALC B cells is not
affected by FRC-restricted MyD88 ablation [16] indi-
cating that innate-B cell function and T cell-dependent B
cell immune responses are supported by distinct FALC
stromal cell population. In support of this, IgM producing
B cells are found in the periphery of FALCs while IgMlow
B cells are found in the centre of the cluster [10,11].
Conclusions
Here we discussed how the structure and function of
FALCs is supported by unique subsets of stromal cells.
FALCs are emerging as critical regulators of serous cavity
immune function at homeostasis and during infection
and inflammation. Recent studies have shed considerable
light on the importance of the adipose stromal cell
niche for the establishment and function of the immune
compartment of the serous cavities and adipose tissues.
Future studies will benefit from genetic tools that will
enable targeted deletion and modification of specific
subsets of adipose stromal cells including those within
FALCs. As immune-adipose tissues are increasingly
recognised for the key roles they play in the regulation
of whole body homeostasis, metabolism & disease there is
an urgent need to expedite the development of such
tools.
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